Medical Marijuana, Inc. v. ProjectCBD.com

CourtCalifornia Court of Appeal
DecidedMarch 20, 2020
DocketD074755
StatusPublished

This text of Medical Marijuana, Inc. v. ProjectCBD.com (Medical Marijuana, Inc. v. ProjectCBD.com) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Medical Marijuana, Inc. v. ProjectCBD.com, (Cal. Ct. App. 2020).

Opinion

Filed 3/20/20 CERTIFIED FOR PUBLICATION

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

MEDICAL MARIJUANA, INC., et al., D074755

Plaintiffs and Respondents,

v. (Super. Ct. No. 37-2014-00036039- CU-DF-CTL) PROJECTCBD.COM et al.,

Defendants and Appellants.

APPEAL from an order of the Superior Court of San Diego County,

Joel R. Wohlfeil, Judge. Reversed.

Greenberg Traurig and Tyler R. Andrews for Defendants and Appellants.

Procopio, Cory, Hargreaves & Savitch, Kendra J. Hall and Michael R. Kiesling for

Plaintiffs and Respondents.

I.

INTRODUCTION

This case arises from the publication of an article regarding the safety of a

cannabidiol (CBD) product, Real Scientific Hemp Oil (RSHO), sold by plaintiffs Medical

Marijuana, Inc. (MMI) and HempMeds PX, LLC (HempMeds) (jointly the plaintiffs).

The plaintiffs contend that the article contains false information about RSHO and that the named defendants who were involved in the publication of the article, including

ProjectCBD.com (Project CBD), the website entity on which the article was published,

Martin Lee, the founder of ProjectCBD.com, and Aaron Miguel Cantu, the author of the

article (jointly "the Project CBD defendants"), should be held liable for libel, false light,

and unfair competition due to their publication of the article.1

The Project CBD defendants appeal from the trial court's order denying their

special motion to strike the three causes of action asserted in the second amended

complaint. The Project CBD defendants contend that the trial court erred in denying their

motion because the plaintiffs failed to demonstrate a probability of prevailing on their

claims.

We conclude that the trial court erred in determining that the plaintiffs have

demonstrated a probability of prevailing on the merits of their claims. We therefore

reverse the trial court's order and remand the matter with directions to enter an order

granting the Project CBD defendants' anti-SLAPP motion.

1 In a prior appeal, Medical Marijuana, Inc. v. ProjectCBD.com (2016) 6 Cal.App.5th 602 (Medical Marijuana), the Project CBD defendants appealed the trial court's denial of their anti-SLAPP motion with respect to the first amended complaint. (Id., at p. 606.) We affirmed the trial court's denial, on the ground that the allegations of the relevant causes of action did not include any conduct on the part of the Project CBD defendants, and in fact specifically excluded the publication of the Article by limiting the dates on which conduct underlying the causes of action were alleged to have occurred. The first amended complaint thus failed to state any claims at all as to the Project CBD defendants; consequently, there were no claims alleged against the Project CBD defendants that could be stricken from the complaint pursuant to their anti-SLAPP motion. (Id. at p. 621.)

2 II.

FACTUAL AND PROCEDURAL BACKGROUND

A. Factual background2

1. The parties involved in this appeal

Plaintiff MMI is an Oregon corporation, doing business in California. Plaintiff

HempMeds is a California limited liability company and a wholly owned subsidiary of

MMI. HempMeds manufactures and sells RSHO, which contains CBD derived from the

hemp plant. MMI also holds interests in an entity called KannaLife Sciences, Inc.

(KannaLife), which has its principal place of business in the State of New York.

Defendant Project CBD is registered as a California nonprofit C-corporation,

formed "for the public purpose of education regarding research into the medical utility of

cannabidiol (CBD) and other components of the cannabis plant." Defendant Martin Lee

is Project CBD's founder. Defendant Aaron Miguel Cantu is the author of Hemp Oil

Hustlers: A Project CBD Special Report on Medical Marijuana Inc., HempMeds &

Kannaway ("the Hemp Oil Hustlers Article" or "the Article"), which was published on

the Project CBD Web site. The allegations of the second amended complaint are based

on the publication of this article.

2 Because we are reviewing the record on the court's ruling on the Project CBD defendants' anti-SLAPP motion made in response to the second amended complaint, we take this factual background from the allegations of the operative complaint, as well as from evidence presented to the court with respect to this anti-SLAPP motion.

3 2. The factual allegations in the operative pleading giving rise to the lawsuit

According to the operative pleading, Jason Cranford was previously a board

member of KannaLife. In late March 2014, Cranford resigned from the board of

KannaLife and began to sell CBD products in direct competition with plaintiffs' product,

RSHO, through a medical marijuana dispensary that he owns and operates called Rifle

Mountain, LLC.

The second amended complaint alleges that on or around April 26, 2014, Cranford

posted on Facebook that he intended to have RSHO tested at a diagnostic lab. Cranford

also allegedly posted on Facebook that a child had become ill after having a bad reaction

to RSHO.

Rather than having the RSHO sample tested at the facility that Cranford identified

in his April 26, 2014 Facebook posting, Cranford is alleged to have taken the sample to

Stewart Environmental Consultants, LLC (Stewart Labs) to be tested for "volatile organic

compounds and heavy metal concentrations." According to the pleading, in late May

2014, Stewart Labs released to Cranford a "preliminary report" regarding the RSHO

sample. The plaintiffs allege that after receiving this preliminary report, Cranford

"released copies of 'preliminary' test results" from Stewart Labs's testing.3

3 The second amended complaint suggests that Cranford "released" copies of these " 'preliminary' test results from Stewart" by stating in a Facebook post that the results had been posted on someone else's Facebook page.

4 According to the operative complaint, on May 30, 2014, Stewart Labs "published

the complete and final test results" from its analysis of the "purported RSHO sample" that

Cranford had submitted. The plaintiffs allege that "[t]he final results showed

significantly different reporting values than the preliminary results, especially for heavy

metals such as lead, molybdenum, nickel, selenium, and silver, among others." The

plaintiffs further allege that despite being aware of the Stewart Labs final test results, on

June 1, 2014, Cranford posted a link to a statement written on Facebook by " 'Sarah

Hadigan' " who asserted that her " 'daughter is dead because of this product[, i.e.,

RSHO].' "

The plaintiffs allege that in early June 2014, Stewart Labs stated in an e-mail "that

the preliminary test results published by Cranford were not accurate, [and] that the

sample was possibly contaminated as it had been handled by three different custodians

without a proper chain of custody . . . and should not have been published."

According to the operative pleading, on October 14, 2014, the Project CBD

defendants "published" defendant Cantu's Hemp Oil Hustlers Article on Project CBD's

Web site. In a section titled "FACTS COMMON TO ALL CLAIMS" (boldface &

underscoring omitted), the plaintiffs allege the following with respect to the Hemp Oil

Hustlers Article:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Curtis Publishing Co. v. Butts
388 U.S. 130 (Supreme Court, 1967)
Philadelphia Newspapers, Inc. v. Hepps
475 U.S. 767 (Supreme Court, 1986)
Oasis West Realty v. Goldman
250 P.3d 1115 (California Supreme Court, 2011)
Zhang v. Superior Court
304 P.3d 163 (California Supreme Court, 2013)
GetFugu, Inc. v. Patton Boggs LLP
220 Cal. App. 4th 141 (California Court of Appeal, 2013)
Barrington v. A. H. Robins Co.
702 P.2d 563 (California Supreme Court, 1985)
Cunningham v. Simpson
461 P.2d 39 (California Supreme Court, 1969)
Baker v. Los Angeles Herald Examiner
721 P.2d 87 (California Supreme Court, 1986)
Lipman v. Brisbane Elementary School District
359 P.2d 465 (California Supreme Court, 1961)
Okun v. Superior Court
629 P.2d 1369 (California Supreme Court, 1981)
Selleck v. Globe International, Inc.
166 Cal. App. 3d 1123 (California Court of Appeal, 1985)
Bartalo v. Superior Court
51 Cal. App. 3d 526 (California Court of Appeal, 1975)
Estate of Archer
193 Cal. App. 3d 238 (California Court of Appeal, 1987)
Kahn v. Bower
232 Cal. App. 3d 1599 (California Court of Appeal, 1991)
Aisenson v. American Broadcasting Co.
220 Cal. App. 3d 146 (California Court of Appeal, 1990)
Albertini v. Schaefer
97 Cal. App. 3d 822 (California Court of Appeal, 1979)
Gilbert v. Sykes
53 Cal. Rptr. 3d 752 (California Court of Appeal, 2007)
M. G. v. Time Warner, Inc.
107 Cal. Rptr. 2d 504 (California Court of Appeal, 2001)
Robinzine v. Vicory
50 Cal. Rptr. 3d 65 (California Court of Appeal, 2006)
Gallagher v. Connell
20 Cal. Rptr. 3d 673 (California Court of Appeal, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
Medical Marijuana, Inc. v. ProjectCBD.com, Counsel Stack Legal Research, https://law.counselstack.com/opinion/medical-marijuana-inc-v-projectcbdcom-calctapp-2020.